Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 3
1965 15
1966 59
1967 58
1968 47
1969 56
1970 36
1971 46
1972 42
1973 37
1974 63
1975 40
1976 49
1977 49
1978 47
1979 35
1980 44
1981 34
1982 38
1983 41
1984 36
1985 33
1986 42
1987 27
1988 43
1989 61
1990 34
1991 38
1992 62
1993 43
1994 48
1995 57
1996 56
1997 55
1998 62
1999 76
2000 61
2001 85
2002 74
2003 89
2004 93
2005 105
2006 129
2007 135
2008 147
2009 166
2010 158
2011 147
2012 129
2013 128
2014 150
2015 145
2016 138
2017 111
2018 121
2019 88
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

3,851 results
Results by year
Filters applied: . Clear all
Page 1
Recent advances in understanding and managing acute pancreatitis.
Mandalia A, et al. F1000Res 2018 - Review. PMID 30026919 Free PMC article.
This review highlights advances made in recent years in the diagnosis and management of acute pancreatitis (AP). We focus on epidemiological, clinical, and management aspects of AP. ...This review also highlights the importance of preventive interventions to reduce hospital readmission or prevent pancreatitis, including alcohol and smoking cessation, same-admission cholecystectomy for acute biliary pancreatitis, and chemoprevention and fluid administration for post-ERCP pancreatitis. ...
This review highlights advances made in recent years in the diagnosis and management of acute pancreatitis (AP). We focus on epidemio …
Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis: Summary of the Working Group on Drug Development and Trials in Acute Pancreatitis at the National Institute of Diabetes and Digestive and Kidney Diseases Workshop.
Abu-El-Haija M, et al. Pancreas 2018. PMID 30325856 Free PMC article.
A workshop was sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases to focus on research gaps and opportunities on drug development for pancreatitis. This conference was held on July 25, 2018, and structured into 3 working groups (WG): acute pancreatitis (AP) WG, recurrent AP WG, and chronic pancreatitis WG. ...
A workshop was sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases to focus on research gaps and opportunities …
Prophylactic antibiotics in acute pancreatitis: endless debate.
Mourad MM, et al. Ann R Coll Surg Engl 2017. PMID 27917667 Free PMC article.
There is agreement that in mild pancreatitis there is no need to use antibiotics; in severe pancreatitis it would appear to be a logical choice to use antibiotics to prevent secondary pancreatic infection and decrease associated mortality. ...Despite the many other factors that should be considered, prompt antibiotic therapy is recommended once inflammatory markers are raised, to prevent secondary pancreatic infection. ...
There is agreement that in mild pancreatitis there is no need to use antibiotics; in severe pancreatitis it would appear to be …
Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis: Summary of the Working Group on Drug Development and Trials in Recurrent Acute Pancreatitis at the National Institute of Diabetes and Digestive and Kidney Diseases Workshop.
Lowe ME, et al. Pancreas 2018. PMID 30325857 Free PMC article.
Recurrent acute pancreatitis (RAP) is a complex clinical syndrome with significant morbidity, unpredictable outcomes, and limited treatment options. ...Recurrent acute pancreatitis includes all the risk of acute pancreatitis and often progresses to chronic pancreatitis with variable complications of chronic pain, exocrine insufficiency, diabetes, and pancreatic cancer. ...
Recurrent acute pancreatitis (RAP) is a complex clinical syndrome with significant morbidity, unpredictable outcomes, and limited tre …
Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis: Summary of the Working Group on Drug Development and Trials in Chronic Pancreatitis at the National Institute of Diabetes and Digestive and Kidney Diseases Workshop.
Forsmark CE, et al. Pancreas 2018. PMID 30325858 Free PMC article.
The lack of effective therapeutic agents specifically tailored for chronic pancreatitis (CP) has hampered clinical care and negatively impacted patients' lives. ...The goal is to frame the essential aspects of trial design including patient-centered outcomes, proposed methods to measure the outcomes of pain and progression, and study design considerations for future trials to facilitate rapid drug development for patients with CP....
The lack of effective therapeutic agents specifically tailored for chronic pancreatitis (CP) has hampered clinical care and negativel …
Accelerating the Drug Delivery Pipeline for Acute and Chronic Pancreatitis-Knowledge Gaps and Research Opportunities: Overview Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.
Uc A, et al. Pancreas 2018. PMID 30325855 Free PMC article.
Three separate working groups (acute pancreatitis, recurrent acute pancreatitis, and chronic pancreatitis) were formed to address the needs, gaps, and opportunities. ...This article represents the summary of the overview presentations at the National Institute of Diabetes and Digestive and Kidney Diseases workshop including an ongoing drug trial in acute pancreatitis; a successful drug development network developed by the Cystic Fibrosis Foundation; and considerations for subject selection in drug trials, incorporating Food and Drug Administration guidelines on clinical trial design and clinical outcome measures. ...
Three separate working groups (acute pancreatitis, recurrent acute pancreatitis, and chronic pancreatitis) were formed …
Corticosteroid therapy for severe acute pancreatitis: a meta-analysis of randomized, controlled trials.
Dong LH, et al. Int J Clin Exp Pathol 2015 - Review. PMID 26339332 Free PMC article.
BACKGROUND: Recent reports about the benefits of corticosteroid therapy in patients with severe acute pancreatitis (SAP) have shown conflicting results. ...CONCLUSION: Corticosteroid therapy may improve outcomes in patients with SAP....
BACKGROUND: Recent reports about the benefits of corticosteroid therapy in patients with severe acute pancreatitis (SAP) have …
Intensive insulin therapy in severe acute pancreatitis: a meta-analysis and systematic review.
Li J, et al. West Indian Med J 2012 - Review. PMID 23441350
OBJECTIVE: To assess the effect of intensive insulin therapy on outcomes of patients with severe acute pancreatitis. METHODS: Relevant literatures cited in these electronic databases: Medline, Chinese Biomedical Literature Database, China National Knowledge Infrastructure (CNK1) database, and Excerpta Medical database (Embase) were systematically searched for randomized controlled trials (RCTs) in which intensive insulin therapy was used in severe acute pancreatitis. ...CONCLUSION: In patients with severe acute pancreatitis, intensive insulin therapy could relieve the patient's condition earlier and shorten the length of hospitalization without serious adverse effect....
OBJECTIVE: To assess the effect of intensive insulin therapy on outcomes of patients with severe acute pancreatitis. METHODS: …
Antioxidant therapy in the management of acute, chronic and post-ERCP pancreatitis: a systematic review.
Mohseni Salehi Monfared SS, et al. World J Gastroenterol 2009 - Review. PMID 19777606 Free PMC article.
We systematically reviewed the clinical trials which recruited antioxidants in the therapy of pancreatitis and evaluated whether antioxidants improve the outcome of patients with pancreatitis. ...In conclusion, the present data do not support a benefit of antioxidant therapy alone or in combination with conventional therapy in the management of AP, CP or PEP. ...
We systematically reviewed the clinical trials which recruited antioxidants in the therapy of pancreatitis and evaluated wheth …
3,851 results
Jump to page
Feedback